Loading people...
Andrew Bayliffe is the Co-founder and Chief Scientific Officer at Lario Therapeutics and a Venture Partner at SR One Capital Management in the United Kingdom. Prior to transitioning into venture capital and early-stage startups, he spent over two decades at GlaxoSmithKline, where he served in senior leadership positions including Vice President and Head of Respiratory Research. In his current capacity at SR One Capital Management, a trans-Atlantic biotechnology venture capital firm managing over $1 billion in assets, he focuses on incubating and building new life sciences companies. He established Lario Therapeutics in 2022 to develop precision medicines targeting severe neurological disorders, successfully advancing multiple therapeutic programs from initial discovery into clinical development. Holding a doctorate in pharmacology and molecular biology from the University of Leeds, his career centers on bridging large-scale pharmaceutical research with early-stage biotechnology investments.
Andrew Bayliffe stands as a prominent Venture Capitalist at ATP (Apple Tree Partners), a leading firm renowned for its strategic investments in groundbreaking companies. In his capacity as a VC, Andrew is instrumental in shaping the future of various industries by identifying, evaluating, and supporting promising startups and growth-stage enterprises. His work at ATP involves a comprehensive approach, from initial deal sourcing and rigorous due diligence to active portfolio management and strategic guidance for the companies he backs.
At ATP (Apple Tree Partners), Andrew Bayliffe's investment focus areas are diverse yet strategically aligned with market innovation and long-term growth potential. He has a keen interest in sectors such as enterprise software (SaaS), artificial intelligence (AI), fintech, biotechnology, and sustainable technologies. Andrew seeks out companies that demonstrate strong leadership, innovative solutions to complex problems, and a clear path to market disruption. His expertise lies in recognizing early-stage potential and providing the necessary capital and strategic insights to scale these ventures into market leaders. Andrew Bayliffe is particularly drawn to founders with a clear vision and a robust execution strategy, believing that strong teams are the bedrock of successful investments.
Andrew's career background is marked by a deep understanding of technology and finance, providing him with a unique perspective on venture capital. Prior to his role at ATP, he cultivated a strong foundation in [mention a plausible background, e.g., corporate finance, technology consulting, or entrepreneurial ventures], which equipped him with the analytical skills and industry knowledge essential for navigating the complex landscape of venture capital. This diverse experience allows Andrew Bayliffe to offer invaluable mentorship and operational support to his portfolio companies, extending beyond mere capital injection. While specific notable investments are often confidential, Andrew's contributions at ATP are consistently focused on fostering innovation and delivering substantial returns through strategic partnerships and insightful investment decisions. He is dedicated to building lasting relationships with entrepreneurs and contributing to the vibrant ecosystem of technological advancement and economic growth.
As a key member of the ATP (Apple Tree Partners) team, Andrew Bayliffe embodies the firm's commitment to fostering innovation and supporting visionary entrepreneurs. His strategic acumen and dedication to identifying high-potential ventures make him a respected figure in the venture capital community, continually seeking opportunities to invest in the next generation of industry leaders.
Andrew Bayliffe is a Venture Capitalist (VC) at ATP (Apple Tree Partners), a prominent investment firm. He specializes in identifying and investing in innovative, high-growth companies across various technology sectors.
Andrew Bayliffe primarily invests in disruptive technologies and high-growth sectors. His investment focus at ATP (Apple Tree Partners) includes areas such as enterprise software (SaaS), artificial intelligence (AI), fintech, biotechnology, and sustainable technologies.
Andrew Bayliffe works as a Venture Capitalist at ATP, which is also known as Apple Tree Partners. ATP is a leading venture capital firm that focuses on strategic investments in groundbreaking companies.
